Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats

Synapse

Volumn 46, Issue 4, 2002, Pages 240-250

  Gardner, Eliot L ^a   Schiffer, Wynne K ^b   Horan, Bryan A ^b   Highfield, David ^a   Dewey, Stephen L ^b,c   Brodie, Jonathan D ^c   Ashby Jr , Charles R ^d  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d ST JOHN'S UNIVERSITY   (United States)

Author keywords

Cocaine; Gamma vinyl GABA; Locomotion; Sensitization; Stereotypy

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE; 4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; COCAINE; VIGABATRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; ENZYME INHIBITION; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RATING SCALE; SCORING SYSTEM; SENSITIZATION; STEREOTYPY; TREATMENT OUTCOME;

EID: 0037114069     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/syn.10138     Document Type: Article

References (78)

1. Ashby Jr CR, Rohatgi R, Ngosuwan J, Borda T, Gerasimov MR, Morgan AE, Brodie JD, Kushner S, Dewey SL. 1999. Implications of the GABAB receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 32:51-53.
2. Bartlett E, Hallin A, Chapman B, Angrist B. 1997. Selective sensitization to the psychosis-inducing effects of cocaine: Possible marker for addiction relapse vulnerability? Neuropsychopharmacology 16: 77-82.
3. Berridge KC, Robinson TE. 1998. What is the role of dopamine in reward: Hedonic impact, reward learning, or incentive salience? Brain Res Rev 28:309-369.
4. Bertrand S, Ng GYK, Purisai MG, Wolfe SE, Severidt MW, Nouel D, Robitaille R, Low MJ, O'Neill GP, Metters K, Lacaille JC, Chronwall BM, Morris SJ. 2001. The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain γ-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J Pharmacol Exp Ther 298:15-24.
5. Bohlen P, Huot S, Palfreyman MG. 1979. The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res 167:297-305.
6. Churchill L, Swanson CJ, Urbina M, Kalivas PW. 1999. Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental areas of rats that develop behavioral sensitization. J Neurochem 72:2397-2403.
7. Cunningham KA, Paris JM, Goeders NE. 1992a. Serotonin neurotransmission in cocaine sensitization. Ann NY Acad Sci 654:117-127.
8. Cunningham KA, Paris JM, Goeders NE. 1992b. Chronic cocaine enhances serotonin autoregulation and serotonin binding. Synapse 11:112-123.
9. De Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ. 1998. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci 10:3565-3571.
10. De Vries TJ, Schoffelmeer AN, Binnekade R, Vanderschuren LJ. 2002. Relapse to cocaine- and heroin-seeking behavior mediated by dopamine D2 receptors is time-dependent and associated with behavioral sensitization. Neuropsychopharmacology 26:18-26.
11. Dewey SL, Chaurasia CS, Chen CE, Volkow ND, Clarkson FA, Porter SP, Straughter-Moore RM, Alexoff DL, Tedeschi D, Russo NB, Fowler JS, Brodie JD. 1997. GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25:393-398.
12. Dewey SL, Morgan AE, Ashby Jr CR, Horan B, Gardner EL, Logan J, Volkow ND, Fowler JS, Kushner SA, Brodie JD. 1998. A novel strategy for the treatment of cocaine addiction. Synapse 30:119-119.
13. Downs AW, Eddy NB. 1932. The effect of repeated doses of cocaine on the rat. J Pharmacol Exp Ther 46:199-210.
14. Gasior M, Ungard JT, Witkin JM. 1999. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J Pharmacol Exp Ther 290:1148-1156.
15. Gerfen CR. 1992. The neostriatal mosaic: Multiple levels of compartmental organization. Trends Neurosci 4:133-138.
16. Goeders NE, Irby BD, Shuster CC, Guerin GF. 1997. Tolerance and sensitization to the behavioral effects of cocaine in rats: Relationship to benzodiazepine receptors. Pharmacol Biochem Behav 57:43-56.
17. Gorelick DA, Rothman RB. 1997. Stimulant sensitization in humans. Biol Psychiatry 42:230-231.
18. Heidbreder C, Shoaib M, Shippenberg TS. 1996. Differential role of delta-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur J Pharmacol 298:207-216.
19. Henry DJ, White FJ. 1995. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15:6287-6299.
20. Hettmansperger TP. 1984. Statistical inference based on ranks. New York: John Wiley & Sons. Itzhak Y, Martin JL. 2000. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology 151: 226-233.
21. Hettmansperger TP. 1984. Statistical inference based on ranks. New York: John Wiley & Sons. Itzhak Y, Martin JL. 2000. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology 151: 226-233.
22. Jung MJ, Lippert B, Metcalf BW, Bohlen P, Schechter PJ. 1977. γ-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: Effects on brain GABA metabolism in mice. J Neurochem 29:797-802.
23. Jung BJ, Dawson Jr R, Sealey SA, Peris J. 1999. Endogenous GABA release is reduced in the striatum of cocaine-sensitized rats. Synapse 34:103-110.
24. Kalivas PW. 1993. Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18:75-113.
25. Kalivas PW. 1995. Interactions between dopamine and excitatory amino acids in behavioral sensitization to psychostimulants. Drug Alcohol Depend 37:95-100.
26. Kalivas PW, Duffy P. 1998. Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J Neurochem 70:1497-1502.
27. Kalivas PW, Stewart J. 1991. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16:223-244.
28. Kalivas PW, Sorg BA, Hooks MS. 1993. The pharmacology and neural circuitry of sensitization to psychostimulants. Behav Pharmacol 4:315-334.
29. Kalivas PW, Pierce RC, Cornish J, Sorg BA. 1998. A role for sensitization in craving and relapse in cocaine addiction. J Psychopharmacol 12:49-53.
30. Karler R, Calder LD, Bedingfield JB. 1994. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 115: 305-310.
31. Kelly KM. 1998. Gabapentin: Antiepileptic mechanism of action. Neuropsychobiology 38:139-144.
32. King GR, Xiong Z, Ellinwood Jr EH. 1997. Blockade of cocaine-sensitization by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine. Psychopharmacology 130:159-165.
33. King GR, Xiong Z, Douglass S, Ellinwood Jr EH. 2000. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist. Eur J Pharmacol 394:97-101.
34. nd Ed. Monterey, CA: Brooks/Cole.
35. Koob GF, Nestler EJ. 1997. The neurobiology of drug addiction. J Neuropsychiatry Clin Neurosci 9:482-497.
36. 35SGTPγS binding. Life Sci 69:1093-1102.
37. Kushner SA, Dewey SL, Kornetsky C. 1999. The irreversible gammaaminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-802.
38. B receptor agonist. Neuropharmacology 41:965-975.
39. Lee MA, Paris JM, Cunningham KA. 1991. Cocaine-induced behavioral sensitization is not associated with loss of immunoreactive neurons in the amygdala. Brain Res 545:352-354.
40. Lippert B, Metcalf BW, Jung MJ, Casara P. 1977. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur J Biochem 74:441-445.
41. Mattson RH, Petroff OA, Rothman D, Behar K. 1995. Vigabatrin: Effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurol Scand (Suppl) 162:27-30.
42. Mazurkiewicz M, Sirvio J, Riekkinen Sr P. 1992. Effects of single and repeated administration of vigabatrin on the performance of rats in a 5-choice serial reaction time task. Epilepsy Res 13:231-237.
43. Mazurkiewicz M, Sirvio J, Riekkinen Sr P. 1993. Effects of single and repeated administration of vigabatrin on the performance of nonepileptic rats in a delayed non-matching to position task. Epilepsy Res 15:221-227.
44. Meshul CK, Noguchi K, Emre N, Ellison G. 1998. Cocaine-induced changes in glutamate and GABA immunolabeling within rats habenula and nucleus accumbens. Synapse 30:211-220.
45. nd Ed. New York: Chapman-Hall.
46. Morgan AE, Dewey SL. 1998. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28:60-65.
47. Ng GYK, Bertrand S, Sullivan R, Ethier N, Wang J, Yergey J, Belley M, Trimble L, Bateman K, Alder L, Smith A, McKernan R, Metters K, O'Neill GP, Lacaille JC, Hebert TE. 2001. γ-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol Pharmacol 59:144-152.
48. Palfreyman MG, Schechter PJ, Buckett WR, Tell GP, Koch-Weser J. 1981. The pharmacology of GABA-transaminase inhibitors. Biochem Pharmacol 30:817-824.
49. Pecnis-Thompson M, Peris J. 1993. Behavioral and neurochemical changes caused by repeated ethanol and cocaine administration. Psychopharmacology 110:443-450.
50. Peris J. 1996. Repeated cocaine injections decrease the function of striatal gamma-aminobutyric acid (A) receptors. J Pharmacol Exp Ther 276:1002-1008.
51. Peris J, Boyson SJ, Cass WA, Curella P, Dwoskin LP, Larson G, Lin LH, Yasuda RP, Zanhiser NR. 1990. Persistence of neurochemical changes in dopamine systems after repeated cocaine administration. J Pharmacol Exp Ther 253:38-44.
52. A receptor proteins decrease GABA-stimulated chloride uptake and increase cocaine sensitivity in rats. Mol Brain Res 57:310-320.
53. Petroff OA, Rothman DL. 1998. Measuring human brain GABA in vivo: Effects of GABA-transaminase inhibition with vigabatrin. Mol Neurobiol 16:97-121.
54. Petroff OA, Hyder F, Rothman DL, Mattson RH. 2000. Effects of gabapentin on brain GABA, homocarnosine and pyrrolidinone in epilepsy patients. Epilepsia 41:675-680.
55. Pierce RC, Kalivas PW. 1997. A circuitry of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25:192-216.
56. Pierce RC, Reeder DC, Hicks J, Morgan ZR, Kaiivas PW. 1998. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience 82:1103-1114.
57. Post RM, Contel NR. 1983. Human and animal studies of cocaine: Implications for development of behavioral pathology. In: Creese I, editor. Stimulants: Neurochemical, Behavioral and Clinical Perspectives. New York: Raven Press. p 169-203.
58. Post RM, Weiss SR, Pert A. 1992. Sensitization and kindling effects of chronic cocaine administration. In: Cocaine: Pharmacology, Physiology and Clinical Strategies. Lakoski JM, Galloway MP, White FJ, editors. Caldwell, NJ: Telford Press. p 115-161.
59. 3 subunit knockout mice. J Neurochem 73:1539-1548.
60. Robinson TE, Berridge KC. 2001. Incentive-sensitization and addiction. Addiction 96:103-114.
61. Rockhold RW. 1998. Glutamatergic involvement in psychomotor stimulant action. Prog Drug Res 50:155-192.
62. Rothman RB, Gorelick DA, Baumann MH, Guo KY, Herning RI, Pickworth G, Gendron TM, Koeppl B, Thomson III LE, Henningfield JE. 1994. Lack of evidence for context-dependent cocaine-induced sensitization in humans: Preliminary studies. Pharmacol Biochem Behav 49:583-588.
63. Sala M, Braida D, Colombo M, Gropetti A, Sacco S, Gori A, Parenti M. 1995. Behavioral and biochemical evidence of opioidergic involvement in cocaine sensitization. J Pharmacol Exp Ther 274:450-457.
64. Scheel-Kruger J. 1986. Dopamine-GABA interactions: Evidence that GABA transmits, modulates and mediates dopaminergic function in the basal ganglia and the limbic system. Acta Neurol Scand (Suppl) 107:1-54.
65. Schenk S, Davidson ES. 1998. Stimulant preexposure sensitizes rats and humans to the rewarding effects of cocaine. NIDA Res Monogr Ser 169:56-82.
66. Schenk S, Snow S. 1994. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res 659:17-22.
67. Shippenberg TS, Rea W. 1997. Sensitization to the behavioral effects of cocaine: Modulation by dynorphin and kappa-opioid receptor agonists. Pharmacol Biochem Behav 57:449-455.
68. Shippenberg TS, LeFevour A, Heidbreder C. 1996. Kappa-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J Pharmacol Exp Ther 276:545-554.
69. Spanagel R. 1995. Modulation of drug-induced sensitization processes by endogenous opioid systems. Behav Brain Res 70:37-49.
70. Stringer JL, Lorenzo N. 1999. The reduction in paired-pulse inhibition in the rat hippocampus by gabapentin is independent of GABA(B) receptor activation. Epilepsy Res 33:169-176.
71. Taylor CP. 1997. Mechanisms of action of gabapentin. Rev Neurol 153(Suppl):S39-45.
72. Tzschentke TM, Schmidt WJ. 1999. Functional heterogeneity of the rat medial prefrontal cortex: Effects of discrete subarea-specific lesions on drug-induced conditioned place preference and behavioural sensitization. Eur J Neurosci 11:4099-4109.
73. Vanderschuren LJ, Kalivas PW. 2000. Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: A critical review of preclinical studies. Psychopharmacology 151:99-120.
74. White FJ, Henry DJ, Hu XT, Jeziorski M, Ackerman JM. 1992. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system. In: Cocaine: Pharmacology, Physiology, and Clinical Strategies. Lakoski JM, Galloway MP, White FJ, editors. Boca Raton, FL: CRC Press. p 261-293.
75. nd Ed. New York: McGraw-Hill.
76. Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:679-720.
77. Zahniser NR, Peris J. 1992. Neurochemical mechanisms of cocaine-induced sensitization. In: Cocaine: Pharmacology, Physiology and Clinical Strategies. Lakoski JM, Galloway MP, White FJ, editors. Caldwell, NJ: Telford Press. p 229-260.
78. Ziegler S, Lipton J, Toga A, Ellison G. 1991. Continuous cocaine administration produces persisting changes in brain neurochemistry and behavior. Brain Res 552:27-35.